Biogen Chooses Veeva Vault CRM to Enhance Medicine Delivery Globally

In a significant move towards improving healthcare delivery, Biogen has announced its decision to implement Veeva Vault CRM on a global scale. Veeva Systems, listed on NYSE as VEEV, expressed its pride in supporting Biogen’s mission to bring life-changing therapies to patients around the world.

Tom Schwenger, president and Chief Commercial Officer at Veeva, stated, "We are honored to provide Vault CRM as the agency's commercial foundation for Biogen as it delivers medicines that transform patients' lives." This partnership marks a crucial step in aligning advanced technology with the needs of modern healthcare.

The pharmaceutical and biotechnology sectors are increasingly complex, requiring adaptive strategies to navigate market dynamics. With the integration of Veeva Vault CRM, Biogen aims to enhance its commercial strategy, allowing for a quicker and more effective response to the needs of patients and healthcare providers. Schwenger emphasized the necessity of advanced capabilities in facilitating the introduction of complex treatments to the marketplace. The goal is clear: to speed up the delivery of medicines that significantly impact patient lives globally.

Guy Hadari, Senior Vice President and Global Chief Information Officer at Biogen, echoed these sentiments. He highlighted the strong partnership between Biogen and Veeva, built on a mutual commitment to innovation and customer experience. Hadari remarked, "We are excited to expand our strategic partnership with Veeva by moving to Vault CRM."

Veeva Vault CRM is part of a comprehensive suite of solutions tailored for the pharmaceutical industry. The platform includes the Agentic Call Report, which is designed to generate Commercial Evidence—a critical asset for understanding market demands and shaping appropriate responses. This suite represents a new commercial model that leverages artificial intelligence (AI) to optimize the delivery of medicines.

Veeva Systems is renowned for its industry-specific cloud solutions tailored for life sciences, offering applications, data, and consulting services. They are dedicated to innovation and product excellence, serving over 1,500 clients ranging from established pharmaceutical giants to budding biotech firms. As a Public Benefit Corporation, Veeva prioritizes a balance of interests among its diverse stakeholders, ensuring that their operations contribute positively to society as a whole.

The partnership between Biogen and Veeva is timely, as the healthcare sector faces mounting pressures to innovate and speed up the availability of therapies and treatments to patients. By utilizing Veeva Vault CRM, Biogen is setting the stage for a future where medicines reach those in need faster and more efficiently than ever before.

In conclusion, the adoption of Veeva Vault CRM by Biogen signifies a notable advancement in the approach to commercial strategy in the life sciences sector. This partnership could potentially transform how medicines are delivered globally, ultimately improving patient outcomes and healthcare efficiency. As these two industry leaders align their efforts, the future holds promising possibilities for healthcare innovation.